Roles of TGF-beta in hepatic fibrosis - PubMed (original) (raw)
Review
doi: 10.2741/A812.
Affiliations
- PMID: 11897555
- DOI: 10.2741/A812
Review
Roles of TGF-beta in hepatic fibrosis
Axel M Gressner et al. Front Biosci. 2002.
Abstract
TGF-beta has multiple profibrogenic but also anti-inflammatory and immunosuppressive effects. The balance of these actions is required for maintaining tissue homeostasis and an aberrant expression of TGF-beta is involved in a number of disease processes in the liver. In addition to its fibrogenic action leading to transdifferentiation of hepatic stellate cells into myofibroblasts, TGF-beta is also an important negative regulator of proliferation and an inducer of apoptosis. The major portion of TGF-beta is secreted as part of an inactive complex and the details of the activation process in liver have not yet been elucidated. The initially striking simplicity of the core TGF-beta/Smad signaling pathways is rapidly giving way to a much more complex view of intracellular signal transduction mechanisms and recent work has demonstrated the importance of cross-talk among different signaling pathways to either specify, enhance, or inhibit TGF-beta responses. The ubiquitous pathophysiologic relevance of TGF-beta suggests its measurement in blood as a diagnostic tool. Other strategies aim at inhibition of TGF-beta1 function or synthesis as a primary target for the development of antifibrotic strategies and recent advances in cell biology have opened several ways to approach the inhibition of TGF-beta action.
Similar articles
- Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, Zhang H. Xiang D, et al. Phytomedicine. 2020 Nov;78:153294. doi: 10.1016/j.phymed.2020.153294. Epub 2020 Jul 28. Phytomedicine. 2020. PMID: 32771890 - Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X. Liu H, et al. J Ethnopharmacol. 2018 Jan 10;210:232-241. doi: 10.1016/j.jep.2017.08.029. Epub 2017 Aug 31. J Ethnopharmacol. 2018. PMID: 28864168 - Anti-TGF-beta strategies for the treatment of chronic liver disease.
Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S. Breitkopf K, et al. Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):121S-131S. doi: 10.1097/01.alc.0000189284.98684.22. Alcohol Clin Exp Res. 2005. PMID: 16344596 Review. - Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.
Gressner AM, Weiskirchen R. Gressner AM, et al. J Cell Mol Med. 2006 Jan-Mar;10(1):76-99. doi: 10.1111/j.1582-4934.2006.tb00292.x. J Cell Mol Med. 2006. PMID: 16563223 Free PMC article. Review.
Cited by
- Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave Elastography.
Egresi A, Blázovics A, Lengyel G, Tóth AG, Csongrády B, Jakab Z, Hagymási K. Egresi A, et al. Diagnostics (Basel). 2024 Sep 3;14(17):1945. doi: 10.3390/diagnostics14171945. Diagnostics (Basel). 2024. PMID: 39272729 Free PMC article. - Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy.
Habib S. Habib S. World J Gastrointest Pathophysiol. 2024 Aug 22;15(4):93606. doi: 10.4291/wjgp.v15.i4.93606. World J Gastrointest Pathophysiol. 2024. PMID: 39220834 Free PMC article. Review. - Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma.
Li N, Rodriguez JL, Yin Y, Logun MT, Zhang L, Yu S, Hicks KA, Zhang JV, Zhang L, Xie C, Wang J, Wang T, Xu J, Fraietta JA, Binder ZA, Lin Z, O'Rourke DM. Li N, et al. Mol Ther. 2024 Oct 2;32(10):3522-3538. doi: 10.1016/j.ymthe.2024.07.020. Epub 2024 Jul 31. Mol Ther. 2024. PMID: 39086131 - Epicardial EMT and cardiac repair: an update.
Foglio E, D'Avorio E, Nieri R, Russo MA, Limana F. Foglio E, et al. Stem Cell Res Ther. 2024 Jul 19;15(1):219. doi: 10.1186/s13287-024-03823-z. Stem Cell Res Ther. 2024. PMID: 39026298 Free PMC article. Review. - An Integrative Transcriptome Subtraction Strategy to Identify Human lncRNAs That Specifically Play a Role in Activation of Human Hepatic Stellate Cells.
Ma Y, Harris J, Li P, Jiang C, Sun H, Cao H. Ma Y, et al. Noncoding RNA. 2024 Jun 6;10(3):34. doi: 10.3390/ncrna10030034. Noncoding RNA. 2024. PMID: 38921831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous